Run,Assay Type,AvgSpotLen,Bases,BioProject,BioSample,BioSampleModel,Bytes,Center Name,collection_date,Consent,covanceID (run),crossoverTreatment (run),DATASTORE filetype,DATASTORE provider,DATASTORE region,env_biome,env_feature,env_material,Experiment,geo_loc_name_country,geo_loc_name_country_continent,geo_loc_name,Host,Instrument,lat_lon,Library Name,LibraryLayout,LibrarySelection,LibrarySource,Organism,patientID (run),Platform,ReleaseDate,Sample Name,sequencingRun (run),SRA Study,Timepoint (run)
SRR5799796,AMPLICON,302,170326188,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",116199042,SALIX,2012,public,DS-125613,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979358,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_40,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799797,AMPLICON,302,650797618,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",427995355,SALIX,2012,public,DS-125415,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979357,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_39,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799798,AMPLICON,302,272436616,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",185112914,SALIX,2012,public,DS-125615,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979356,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_36,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799799,AMPLICON,302,292387340,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",189306479,SALIX,2012,public,DS-125419,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979355,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_35,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799800,AMPLICON,302,568707676,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",369578602,SALIX,2012,public,DS-125418,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979354,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_38,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799801,AMPLICON,302,308245058,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",217988140,SALIX,2012,public,DS-126429,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979353,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_37,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799802,AMPLICON,302,447070834,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",288174331,SALIX,2012,public,DS-126471,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979352,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_32,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799803,AMPLICON,302,11156182,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",7568007,SALIX,2012,public,DS-126470,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979351,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_31,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799804,AMPLICON,302,467129976,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",302889755,SALIX,2012,public,DS-125619,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979350,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_34,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799805,AMPLICON,302,163839228,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",117165983,SALIX,2012,public,DS-115933,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979349,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_33,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799806,AMPLICON,302,136988408,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",98066788,SALIX,2012,public,DS-126464,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979348,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_6,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V11
SRR5799807,AMPLICON,302,7053814,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",4679963,SALIX,2012,public,DS-125650,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979347,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_5,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799808,AMPLICON,302,273037596,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",191402346,SALIX,2012,public,DS-115893,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979346,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_8,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799809,AMPLICON,302,549666878,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",354859422,SALIX,2012,public,DS-115892,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979345,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_7,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799810,AMPLICON,302,7035996,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",4743444,SALIX,2012,public,DS-125610,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979344,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_2,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799811,AMPLICON,302,497628050,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",327229092,SALIX,2012,public,DS-126467,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979343,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_1,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799812,AMPLICON,302,391204156,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",262083988,SALIX,2012,public,DS-125652,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979342,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_4,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799813,AMPLICON,302,93143746,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",62642356,SALIX,2012,public,DS-125651,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979341,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_3,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799814,AMPLICON,302,597658604,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",385606810,SALIX,2012,public,DS-115897,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979340,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_10,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799815,AMPLICON,302,549882506,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",353499562,SALIX,2012,public,DS-115896,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979339,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_9,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799816,AMPLICON,302,591439820,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",383171774,SALIX,2012,public,DS-126431,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979338,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_29,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799817,AMPLICON,302,457387154,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",298755429,SALIX,2012,public,DS-126475,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979337,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_30,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799818,AMPLICON,302,279439996,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",187224959,SALIX,2012,public,DS-126430,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979336,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_27,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V11
SRR5799819,AMPLICON,302,42021488,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",28673142,SALIX,2012,public,DS-125661,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979335,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_28,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799820,AMPLICON,302,40706580,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",29026688,SALIX,2012,public,DS-126477,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979334,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_25,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799821,AMPLICON,302,286425860,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",201800376,SALIX,2012,public,DS-125660,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979333,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_26,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799822,AMPLICON,302,64351368,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",41830558,SALIX,2012,public,DS-125421,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979332,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_23,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799823,AMPLICON,302,529148394,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",343506806,SALIX,2012,public,DS-126433,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979331,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_24,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799824,AMPLICON,302,80171336,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",57277020,SALIX,2012,public,DS-125423,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979330,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_21,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799825,AMPLICON,302,469895692,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",320958802,SALIX,2012,public,DS-126432,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979329,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_22,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799826,AMPLICON,302,358372830,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",241576209,SALIX,2012,public,DS-115871,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979328,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_60,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799827,AMPLICON,302,395691876,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",267482726,SALIX,2012,public,DS-115870,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979327,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_59,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799828,AMPLICON,302,430433050,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",282361800,SALIX,2012,public,DS-125597,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979326,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_54,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799829,AMPLICON,302,341091484,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",236898858,SALIX,2012,public,DS-126487,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979325,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_53,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799830,AMPLICON,302,725690598,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",467406543,SALIX,2012,public,DS-125596,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979324,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_52,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799831,AMPLICON,302,361936430,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",257652441,SALIX,2012,public,DS-125398,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979323,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_51,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799832,AMPLICON,302,411763108,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",270126088,SALIX,2012,public,DS-126484,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979322,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_58,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799833,AMPLICON,302,196013704,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",136047746,SALIX,2012,public,DS-126483,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979321,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_57,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799834,AMPLICON,302,543887202,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",352802210,SALIX,2012,public,DS-125397,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979320,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_56,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799835,AMPLICON,302,586332396,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",381689715,SALIX,2012,public,DS-125630,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979319,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_55,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799836,AMPLICON,302,347481200,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",238563979,SALIX,2012,public,DS-125656,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979318,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_45,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799837,AMPLICON,302,81643284,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",58027064,SALIX,2012,public,DS-125810,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979317,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_46,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799838,AMPLICON,302,210189584,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",140469982,SALIX,2012,public,DS-125598,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979316,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_47,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799839,AMPLICON,302,211829746,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",144092036,SALIX,2012,public,DS-126489,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979315,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_48,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799840,AMPLICON,302,201206896,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",139885299,SALIX,2012,public,DS-125657,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979314,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_41,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799841,AMPLICON,302,541271882,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",348570139,SALIX,2012,public,DS-125614,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979313,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_42,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799842,AMPLICON,302,485229440,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",326093467,SALIX,2012,public,DS-126469,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979312,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_43,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V11
SRR5799843,AMPLICON,302,351563032,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",235844873,SALIX,2012,public,DS-125414,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979311,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_44,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799844,AMPLICON,302,555049424,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",358434366,SALIX,2012,public,DS-125599,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979310,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_49,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799845,AMPLICON,302,117351462,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",83633922,SALIX,2012,public,DS-125632,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979309,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_50,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799846,AMPLICON,302,327514470,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",224734470,SALIX,2012,public,DS-126639,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979308,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_72,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799847,AMPLICON,302,527266330,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",359634664,SALIX,2012,public,DS-125627,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979307,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_71,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799848,AMPLICON,302,268068186,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",187691255,SALIX,2012,public,DS-125424,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979306,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_74,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799849,AMPLICON,302,228090030,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",155538158,SALIX,2012,public,DS-126439,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979305,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_73,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799850,AMPLICON,302,338737696,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",225583802,SALIX,2012,public,DS-126437,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979304,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_76,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799851,AMPLICON,302,442807500,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",298047320,SALIX,2012,public,DS-125623,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979303,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_75,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799852,AMPLICON,302,220460604,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",150443217,SALIX,2012,public,DS-126456,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979302,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_78,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799853,AMPLICON,302,423683652,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",283708235,SALIX,2012,public,DS-125400,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979301,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_77,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799854,AMPLICON,302,447065700,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",302012578,SALIX,2012,public,DS-125643,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979300,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_80,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799855,AMPLICON,302,545090672,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",352362174,SALIX,2012,public,DS-125401,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979299,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_79,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799856,AMPLICON,302,189566910,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",136164956,SALIX,2012,public,DS-125405,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979298,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_18,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799857,AMPLICON,302,371266418,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",262855723,SALIX,2012,public,DS-125404,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979297,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_17,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799858,AMPLICON,302,259054090,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",183291385,SALIX,2012,public,DS-125649,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979296,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_16,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799859,AMPLICON,302,32120116,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",22949076,SALIX,2012,public,DS-125407,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979295,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_15,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799860,AMPLICON,302,433877360,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",284783903,SALIX,2012,public,DS-125805,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979294,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_14,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V11
SRR5799861,AMPLICON,302,280597260,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",184326363,SALIX,2012,public,DS-125606,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979293,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_13,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799862,AMPLICON,302,458255404,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",296776773,SALIX,2012,public,DS-115928,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979292,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_12,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799863,AMPLICON,302,563231208,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",365551254,SALIX,2012,public,DS-125609,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979291,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_11,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799864,AMPLICON,302,456183080,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",306545060,SALIX,2012,public,DS-125620,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979290,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_20,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799865,AMPLICON,302,382358576,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",261678160,SALIX,2012,public,DS-126656,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979289,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_19,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799866,AMPLICON,302,220750222,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",157567271,SALIX,2012,public,DS-125636,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979288,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_96,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799867,AMPLICON,302,122398486,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",87614048,SALIX,2012,public,DS-126647,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979287,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_95,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799868,AMPLICON,302,293597152,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",200963638,SALIX,2012,public,DS-126449,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979286,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_94,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799869,AMPLICON,302,446256340,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",286342766,SALIX,2012,public,DS-125635,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979285,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_93,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799870,AMPLICON,302,509679360,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",331340447,SALIX,2012,public,DS-125638,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979284,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_92,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799871,AMPLICON,302,536104360,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",349465470,SALIX,2012,public,DS-115912,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979283,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_91,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799872,AMPLICON,302,436583280,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",298791278,SALIX,2012,public,DS-115867,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979282,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_63,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799873,AMPLICON,302,420245986,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",295181440,SALIX,2012,public,DS-115900,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979281,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_64,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799874,AMPLICON,302,227114268,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",147042269,SALIX,2012,public,DS-126480,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979280,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_61,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799875,AMPLICON,302,367451856,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",259645086,SALIX,2012,public,DS-115872,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979279,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_62,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799876,AMPLICON,302,493404580,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",320454940,SALIX,2012,public,DS-115869,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979278,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_67,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799877,AMPLICON,302,375933526,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",255674158,SALIX,2012,public,DS-115902,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979277,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_68,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799878,AMPLICON,302,313546668,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",214016048,SALIX,2012,public,DS-115944,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979276,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_65,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799879,AMPLICON,302,383222598,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",256136123,SALIX,2012,public,DS-115868,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979275,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_66,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799880,AMPLICON,302,528161156,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",338904270,SALIX,2012,public,DS-125628,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979274,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_69,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799881,AMPLICON,302,541116956,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",348447605,SALIX,2012,public,DS-115907,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979273,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_70,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799882,AMPLICON,302,313525226,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",211774745,SALIX,2012,public,DS-115910,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979272,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_89,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799883,AMPLICON,302,413200326,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",282723424,SALIX,2012,public,DS-115878,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979271,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_90,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799884,AMPLICON,302,449623942,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",292877232,SALIX,2012,public,DS-126454,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979270,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_81,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799885,AMPLICON,302,156207990,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",111898571,SALIX,2012,public,DS-126453,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979269,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_82,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799886,AMPLICON,302,149867500,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",106956035,SALIX,2012,public,DS-115880,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979268,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_83,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V7
SRR5799887,AMPLICON,302,728310750,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",470829543,SALIX,2012,public,DS-115883,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979267,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_84,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799888,AMPLICON,302,548027622,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",352232235,SALIX,2012,public,DS-115885,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979266,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_85,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799889,AMPLICON,302,830434768,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",533734034,SALIX,2012,public,DS-115886,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979265,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_86,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V3
SRR5799890,AMPLICON,302,86946404,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",59440867,SALIX,2012,public,DS-115876,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979264,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_87,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V6
SRR5799891,AMPLICON,302,498593242,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",334369222,SALIX,2012,public,DS-115877,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979263,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate1_88,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate1,SRP110990,V4
SRR5799892,AMPLICON,302,267614582,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",173833477,SALIX,2012,public,DS-126834,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979454,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_69,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799893,AMPLICON,302,525155048,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",335846987,SALIX,2012,public,DS-125625,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979453,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_70,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799894,AMPLICON,302,232810592,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",150010659,SALIX,2012,public,DS-115942,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979452,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_65,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799895,AMPLICON,302,435612350,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",287111504,SALIX,2012,public,DS-126839,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979451,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_66,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799896,AMPLICON,302,415965438,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",274254043,SALIX,2012,public,DS-125624,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979450,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_67,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799897,AMPLICON,302,138760242,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",88991790,SALIX,2012,public,DS-126438,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979449,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_68,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799898,AMPLICON,302,266351920,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",173623812,SALIX,2012,public,DS-126442,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979448,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_61,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799899,AMPLICON,302,171503988,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",112754842,SALIX,2012,public,DS-126640,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979447,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_62,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799900,AMPLICON,302,318945824,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",207147988,SALIX,2012,public,DS-126440,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979446,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_63,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799901,AMPLICON,302,320327172,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",213325148,SALIX,2012,public,DS-126481,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979445,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_64,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799902,AMPLICON,302,104415896,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",67160888,SALIX,2012,public,DS-115891,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979444,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_10,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799903,AMPLICON,302,512699360,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",328085071,SALIX,2012,public,DS-126462,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979443,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_9,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799904,AMPLICON,302,3478738,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",2372878,SALIX,2012,public,DS-126461,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979442,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_8,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799905,AMPLICON,302,140979338,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",91598727,SALIX,2012,public,DS-126860,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979441,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_7,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799906,AMPLICON,302,451336584,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",297775882,SALIX,2012,public,DS-126662,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979440,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_6,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799907,AMPLICON,302,523366604,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",336210552,SALIX,2012,public,DS-126661,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979439,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_5,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799908,AMPLICON,302,209314388,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",134335388,SALIX,2012,public,DS-126463,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979438,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_4,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799909,AMPLICON,302,2666358,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1776095,SALIX,2012,public,DS-126862,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979437,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_3,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799910,AMPLICON,302,243432536,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",158235639,SALIX,2012,public,DS-126465,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979436,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_2,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799911,AMPLICON,302,434966674,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",282339371,SALIX,2012,public,DS-125653,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979435,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_1,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799912,AMPLICON,302,389136966,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",246807250,SALIX,2012,public,DS-126441,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979434,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_60,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799913,AMPLICON,302,362161118,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",238241477,SALIX,2012,public,DS-126444,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979433,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_59,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799914,AMPLICON,302,440521360,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",292335983,SALIX,2012,public,DS-125612,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979432,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_52,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799915,AMPLICON,302,42051386,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",27417482,SALIX,2012,public,DS-126667,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979431,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_51,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799916,AMPLICON,302,354210062,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",228779189,SALIX,2012,public,DS-126822,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979430,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_54,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799917,AMPLICON,302,268977508,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",179725457,SALIX,2012,public,DS-126668,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979429,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_53,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799918,AMPLICON,302,563221242,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",375224752,SALIX,2012,public,DS-126445,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979428,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_56,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799919,AMPLICON,302,457594628,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",296988842,SALIX,2012,public,DS-125631,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979427,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_55,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799920,AMPLICON,302,278608590,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",182483271,SALIX,2012,public,DS-125795,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979426,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_58,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799921,AMPLICON,302,461603980,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",309432394,SALIX,2012,public,DS-126643,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979425,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_57,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799922,AMPLICON,302,366427472,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",236430568,SALIX,2012,public,DS-126826,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979424,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_49,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799923,AMPLICON,302,360121712,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",237695144,SALIX,2012,public,DS-125611,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979423,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_50,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799924,AMPLICON,302,369604512,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",246819528,SALIX,2012,public,DS-115936,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979422,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_43,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799925,AMPLICON,302,327146634,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",218792409,SALIX,2012,public,DS-115937,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979421,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_44,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799926,AMPLICON,302,188582994,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",123992605,SALIX,2012,public,DS-126670,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979420,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_41,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799927,AMPLICON,302,93808750,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",61306979,SALIX,2012,public,DS-126473,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979419,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_42,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799928,AMPLICON,302,217073070,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",143472286,SALIX,2012,public,DS-125618,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979418,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_47,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799929,AMPLICON,302,388401898,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",251576401,SALIX,2012,public,DS-125616,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979417,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_48,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V11
SRR5799930,AMPLICON,302,106147866,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",69525166,SALIX,2012,public,DS-126829,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979416,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_45,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799931,AMPLICON,302,329058898,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",212487606,SALIX,2012,public,DS-125617,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979415,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_46,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799932,AMPLICON,302,402434630,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",263749359,SALIX,2012,public,DS-126472,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979414,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_40,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799933,AMPLICON,302,138438310,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",89851047,SALIX,2012,public,DS-126672,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979413,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_39,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799934,AMPLICON,302,108457260,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",72639840,SALIX,2012,public,DS-126474,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979412,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_38,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799935,AMPLICON,302,415581294,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",270140388,SALIX,2012,public,DS-126675,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979411,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_37,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799936,AMPLICON,302,418092122,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",270450583,SALIX,2012,public,DS-126674,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979410,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_36,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799937,AMPLICON,302,197888218,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",129038391,SALIX,2012,public,DS-126831,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979409,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_35,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799938,AMPLICON,302,386451884,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",257312412,SALIX,2012,public,DS-126479,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979408,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_34,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799939,AMPLICON,302,32101996,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",21182382,SALIX,2012,public,DS-125621,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979407,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_33,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799940,AMPLICON,302,250491484,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",163659063,SALIX,2012,public,DS-126434,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979406,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_32,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799941,AMPLICON,302,229527852,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",146661874,SALIX,2012,public,DS-126811,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979405,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_31,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799942,AMPLICON,302,212013060,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",136066342,SALIX,2012,public,DS-125601,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979404,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_29,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799943,AMPLICON,302,335508108,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",219814840,SALIX,2012,public,DS-126459,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979403,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_30,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799944,AMPLICON,302,285848738,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",188099874,SALIX,2012,public,DS-125604,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979402,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_21,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799945,AMPLICON,302,275191158,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",183279630,SALIX,2012,public,DS-126814,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979401,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_22,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799946,AMPLICON,302,85053468,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",55695115,SALIX,2012,public,DS-126858,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979400,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_23,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799947,AMPLICON,302,518318674,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",342867538,SALIX,2012,public,DS-125605,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979399,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_24,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799948,AMPLICON,302,349524834,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",226992367,SALIX,2012,public,DS-126812,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979398,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_25,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799949,AMPLICON,302,497710496,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",330399469,SALIX,2012,public,DS-126813,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979397,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_26,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799950,AMPLICON,302,407317970,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",267948458,SALIX,2012,public,DS-125600,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979396,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_27,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799951,AMPLICON,302,40510280,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",26669989,SALIX,2012,public,DS-126458,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979395,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_28,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799952,AMPLICON,302,379617322,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",243771652,SALIX,2012,public,DS-126448,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979394,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_96,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799953,AMPLICON,302,435435378,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",288764606,SALIX,2012,public,DS-126447,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979393,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_95,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799954,AMPLICON,302,323885940,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",211657478,SALIX,2012,public,DS-126849,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979392,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_92,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799955,AMPLICON,302,144340900,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",93108504,SALIX,2012,public,DS-126805,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979391,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_91,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V11
SRR5799956,AMPLICON,302,244638120,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",157847031,SALIX,2012,public,DS-125633,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979390,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_94,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799957,AMPLICON,302,314234624,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",202440334,SALIX,2012,public,DS-126806,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979389,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_93,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799958,AMPLICON,302,462477666,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",297395247,SALIX,2012,public,DS-125806,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979388,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_16,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799959,AMPLICON,302,652376172,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",418215242,SALIX,2012,public,DS-125608,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979387,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_15,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799960,AMPLICON,302,392145490,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",251383110,SALIX,2012,public,DS-125807,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979386,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_18,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799961,AMPLICON,302,399747434,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",267335071,SALIX,2012,public,DS-126818,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979385,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_17,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799962,AMPLICON,302,412546798,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",267002370,SALIX,2012,public,DS-115895,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979384,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_12,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799963,AMPLICON,302,182692182,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",118064895,SALIX,2012,public,DS-115894,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979383,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_11,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799964,AMPLICON,302,321265184,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",207204705,SALIX,2012,public,DS-125809,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979382,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_14,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799965,AMPLICON,302,340601942,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",221534554,SALIX,2012,public,DS-125808,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979381,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_13,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799966,AMPLICON,302,251036292,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",161200124,SALIX,2012,public,DS-126817,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979380,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_20,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799967,AMPLICON,302,455758468,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",299056873,SALIX,2012,public,DS-125607,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979379,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_19,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799968,AMPLICON,302,189351886,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",126642242,SALIX,2012,public,DS-126808,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979378,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_89,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V11
SRR5799969,AMPLICON,302,458147590,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",298027765,SALIX,2012,public,DS-125639,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979377,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_90,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799970,AMPLICON,302,401933008,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",259338995,SALIX,2012,public,DS-115879,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979376,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_87,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799971,AMPLICON,302,371113908,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",242910295,SALIX,2012,public,DS-126807,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979375,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_88,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799972,AMPLICON,302,302630274,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",202014466,SALIX,2012,public,DS-126451,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979374,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_85,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799973,AMPLICON,302,505471292,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",324186577,SALIX,2012,public,DS-115955,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979373,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_86,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799974,AMPLICON,302,119896416,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",77001721,SALIX,2012,public,DS-126651,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979372,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_83,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799975,AMPLICON,302,380329438,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",246490705,SALIX,2012,public,DS-126450,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979371,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_84,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799976,AMPLICON,302,351116072,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",230502793,SALIX,2012,public,DS-126452,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979370,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_81,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799977,AMPLICON,302,349337594,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",228569367,SALIX,2012,public,DS-126650,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979369,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_82,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V4
SRR5799978,AMPLICON,302,362309702,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",234926660,SALIX,2012,public,DS-126654,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979368,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_74,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799979,AMPLICON,302,142308138,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",93257367,SALIX,2012,public,DS-126833,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979367,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_73,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V3
SRR5799980,AMPLICON,302,443509046,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",291222106,SALIX,2012,public,DS-126832,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979366,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_72,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V11
SRR5799981,AMPLICON,302,269768446,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",176259688,SALIX,2012,public,DS-126436,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979365,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_71,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799982,AMPLICON,302,169055372,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",111362278,SALIX,2012,public,DS-125641,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979364,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_78,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799983,AMPLICON,302,565671368,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",372863735,SALIX,2012,public,DS-126652,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979363,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_77,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799984,AMPLICON,302,424793502,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",275551630,SALIX,2012,public,DS-126853,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979362,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_76,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5799985,AMPLICON,302,444317198,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",290040531,SALIX,2012,public,DS-126457,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979361,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_75,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799986,AMPLICON,302,74126504,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",49360848,SALIX,2012,public,DS-126851,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979360,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_80,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V6
SRR5799987,AMPLICON,302,319517510,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",205665354,SALIX,2012,public,DS-126455,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979359,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate2_79,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate2,SRP110990,V7
SRR5800002,AMPLICON,302,161078948,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",93244075,SALIX,2012,public,DS-126478,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979564,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_34,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800003,AMPLICON,302,326552902,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",186548592,SALIX,2012,public,DS-125422,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979563,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_33,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800004,AMPLICON,302,406835676,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",234050226,SALIX,2012,public,DS-126657,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979562,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_32,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800005,AMPLICON,302,569550860,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",323447546,SALIX,2012,public,DS-125645,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979561,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_31,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800006,AMPLICON,302,636856996,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",350871619,SALIX,2012,public,DS-126677,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979560,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_38,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800007,AMPLICON,302,3114828,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1968372,SALIX,2012,public,DS-126435,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979559,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_37,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800008,AMPLICON,302,501112526,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",286151903,SALIX,2012,public,DS-126830,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979558,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_36,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800009,AMPLICON,302,612136182,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",336337047,SALIX,2012,public,DS-126676,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979557,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_35,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800010,AMPLICON,302,202605156,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",114219899,SALIX,2012,public,DS-126476,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979556,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_40,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800011,AMPLICON,302,352132000,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",200855426,SALIX,2012,public,DS-125420,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979555,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_39,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800012,AMPLICON,302,714207350,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",397951925,SALIX,2012,public,DS-125644,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979554,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_29,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800013,AMPLICON,302,516628380,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",294544479,SALIX,2012,public,DS-125403,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979553,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_30,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800014,AMPLICON,302,563474922,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",322222963,SALIX,2012,public,DS-125647,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979552,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_25,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800015,AMPLICON,302,395019322,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",225752491,SALIX,2012,public,DS-126659,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979551,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_26,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800016,AMPLICON,302,405387284,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",222634193,SALIX,2012,public,DS-126857,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979550,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_27,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800017,AMPLICON,302,204087674,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",114614975,SALIX,2012,public,DS-125402,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979549,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_28,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800018,AMPLICON,302,435689058,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",242886244,SALIX,2012,public,DS-125602,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979548,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_21,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800019,AMPLICON,302,166034164,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",96775781,SALIX,2012,public,DS-125646,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979547,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_22,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800020,AMPLICON,302,692222052,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",395640810,SALIX,2012,public,DS-126658,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979546,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_23,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800021,AMPLICON,302,397307878,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",220103525,SALIX,2012,public,DS-125603,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979545,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_24,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800022,AMPLICON,302,370871100,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",211286346,SALIX,2012,public,DS-126648,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979544,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_92,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800023,AMPLICON,302,354864496,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",202152584,SALIX,2012,public,DS-126845,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979543,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_91,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800024,AMPLICON,302,582144864,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",330365334,SALIX,2012,public,DS-126843,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979542,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_94,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800025,AMPLICON,302,619183352,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",347002545,SALIX,2012,public,DS-126645,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979541,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_93,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800026,AMPLICON,302,160246636,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",89271539,SALIX,2012,public,DS-126646,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979540,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_96,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800027,AMPLICON,302,497610232,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",286968681,SALIX,2012,public,DS-125634,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979539,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_95,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800028,AMPLICON,302,123936572,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",70492786,SALIX,2012,public,DS-126859,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979538,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_20,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800029,AMPLICON,302,385355624,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",219815268,SALIX,2012,public,DS-126815,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979537,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_19,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V11
SRR5800030,AMPLICON,302,524320018,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",300112699,SALIX,2012,public,DS-126660,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979536,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_12,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800031,AMPLICON,302,594803798,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",335717018,SALIX,2012,public,DS-126664,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979535,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_11,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800032,AMPLICON,302,419270526,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",236479515,SALIX,2012,public,DS-125408,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979534,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_14,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800033,AMPLICON,302,673231688,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",375917169,SALIX,2012,public,DS-126460,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979533,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_13,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800034,AMPLICON,302,493415452,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",278597915,SALIX,2012,public,DS-125409,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979532,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_16,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V11
SRR5800035,AMPLICON,302,285660592,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",159460281,SALIX,2012,public,DS-126816,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979531,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_15,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800036,AMPLICON,302,375954666,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",210058921,SALIX,2012,public,DS-125648,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979530,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_18,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800037,AMPLICON,302,71215526,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",40910051,SALIX,2012,public,DS-125406,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979529,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_17,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800038,AMPLICON,302,42671392,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",24433752,SALIX,2012,public,DS-125640,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979528,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_83,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800039,AMPLICON,302,244261828,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",137099325,SALIX,2012,public,DS-126850,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979527,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_84,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V11
SRR5800040,AMPLICON,302,806695756,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",457805667,SALIX,2012,public,DS-126852,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979526,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_81,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800041,AMPLICON,302,750975548,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",422410711,SALIX,2012,public,DS-126655,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979525,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_82,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800042,AMPLICON,302,500389840,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",278039353,SALIX,2012,public,DS-126809,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979524,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_87,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800043,AMPLICON,302,415717798,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",232242175,SALIX,2012,public,DS-125637,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979523,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_88,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800044,AMPLICON,302,474439584,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",264865787,SALIX,2012,public,DS-126653,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979522,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_85,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800045,AMPLICON,302,51438452,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",29848392,SALIX,2012,public,DS-126170,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979521,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_86,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800046,AMPLICON,302,439235746,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",252030113,SALIX,2012,public,DS-126649,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979520,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_89,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800047,AMPLICON,302,456608598,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",253039926,SALIX,2012,public,DS-126847,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979519,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_90,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800048,AMPLICON,302,446637464,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",254205571,SALIX,2012,public,DS-126466,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979518,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_10,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800049,AMPLICON,302,589099320,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",331154963,SALIX,2012,public,DS-125410,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979517,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_9,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800050,AMPLICON,302,563063900,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",311864950,SALIX,2012,public,DS-125654,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979516,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_4,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800051,AMPLICON,302,367038116,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",206569907,SALIX,2012,public,DS-125412,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979515,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_3,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800052,AMPLICON,302,834946950,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",461922070,SALIX,2012,public,DS-126665,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979514,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_2,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800053,AMPLICON,302,455098598,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",255367229,SALIX,2012,public,DS-125411,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979513,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_1,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800054,AMPLICON,302,168623210,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",94454999,SALIX,2012,public,DS-126861,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979512,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_8,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800055,AMPLICON,302,423096262,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",242626319,SALIX,2012,public,DS-126663,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979511,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_7,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800056,AMPLICON,302,313282418,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",179224939,SALIX,2012,public,DS-126666,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979510,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_6,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800057,AMPLICON,302,545843860,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",302086389,SALIX,2012,public,DS-126468,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979509,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_5,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800058,AMPLICON,302,507415870,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",285710005,SALIX,2012,public,DS-125642,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979508,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_80,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800059,AMPLICON,302,613197712,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",344441220,SALIX,2012,public,DS-126877,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979507,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_79,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800060,AMPLICON,302,492154300,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",273463536,SALIX,2012,public,DS-125622,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979506,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_78,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800061,AMPLICON,302,752517862,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",426982997,SALIX,2012,public,DS-126878,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979505,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_77,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800062,AMPLICON,302,615706426,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",341083776,SALIX,2012,public,DS-126837,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979504,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_76,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800063,AMPLICON,302,596984540,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",334897238,SALIX,2012,public,DS-126836,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979503,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_75,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800064,AMPLICON,302,478365584,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",273536024,SALIX,2012,public,DS-125626,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979502,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_74,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800065,AMPLICON,302,489054270,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",279693248,SALIX,2012,public,DS-125629,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979501,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_73,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800066,AMPLICON,302,474299758,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",262537807,SALIX,2012,public,DS-126482,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979500,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_72,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800067,AMPLICON,302,128781860,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",73284502,SALIX,2012,public,DS-126486,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979499,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_71,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800068,AMPLICON,302,239225978,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",138634610,SALIX,2012,public,DS-126485,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979498,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_69,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800069,AMPLICON,302,265347468,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",146174612,SALIX,2012,public,DS-126881,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979497,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_70,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800070,AMPLICON,302,158264610,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",88809756,SALIX,2012,public,DS-126446,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979496,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_61,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800071,AMPLICON,302,669159520,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",379661787,SALIX,2012,public,DS-126644,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979495,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_62,PAIRED,PCR,METAGENOMIC,human gut metagenome,0596-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800072,AMPLICON,302,350097124,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",199922395,SALIX,2012,public,DS-126842,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979494,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_63,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800073,AMPLICON,302,500992028,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",282428293,SALIX,2012,public,DS-126443,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979493,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_64,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800074,AMPLICON,302,360647796,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",202859850,SALIX,2012,public,DS-126641,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979492,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_65,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800075,AMPLICON,302,607253446,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",333757401,SALIX,2012,public,DS-125399,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979491,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_66,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800076,AMPLICON,302,579788056,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",315194126,SALIX,2012,public,DS-126488,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979490,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_67,PAIRED,PCR,METAGENOMIC,human gut metagenome,0956-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800077,AMPLICON,302,643798466,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",366710508,SALIX,2012,public,DS-126642,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979489,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_68,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800078,AMPLICON,302,586724996,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",325309557,SALIX,2012,public,DS-126868,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979488,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_56,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800079,AMPLICON,302,567902242,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",317687015,SALIX,2012,public,DS-126824,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979487,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_55,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800080,AMPLICON,302,542933486,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",301173522,SALIX,2012,public,DS-125655,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979486,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_58,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800081,AMPLICON,302,471897650,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",269323085,SALIX,2012,public,DS-125413,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979485,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_57,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800082,AMPLICON,302,266706166,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",154587257,SALIX,2012,public,DS-126867,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979484,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_52,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800083,AMPLICON,302,433341008,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",245370831,SALIX,2012,public,DS-126669,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979483,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_51,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800084,AMPLICON,302,839360378,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",461511133,SALIX,2012,public,DS-125658,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979482,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_54,PAIRED,PCR,METAGENOMIC,human gut metagenome,0463-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800085,AMPLICON,302,805965822,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",458721180,SALIX,2012,public,DS-125416,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979481,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_53,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800086,AMPLICON,302,488268466,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",280235431,SALIX,2012,public,DS-126866,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979480,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_60,PAIRED,PCR,METAGENOMIC,human gut metagenome,1112-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V11
SRR5800087,AMPLICON,302,438253038,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",250664412,SALIX,2012,public,DS-126865,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979479,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_59,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800088,AMPLICON,302,445904812,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",247874516,SALIX,2012,public,DS-126828,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979478,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_47,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800089,AMPLICON,302,935180146,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",531595887,SALIX,2012,public,DS-125417,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979477,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_48,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800090,AMPLICON,302,800150208,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",450949314,SALIX,2012,public,DS-126671,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979476,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_45,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800091,AMPLICON,302,410459978,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",232398727,SALIX,2012,public,DS-126827,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979475,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_46,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800092,AMPLICON,302,473574052,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",265606226,SALIX,2012,public,DS-126673,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979474,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_43,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800093,AMPLICON,302,501537138,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",279443807,SALIX,2012,public,DS-126871,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979473,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_44,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V3
SRR5800094,AMPLICON,302,510362182,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",289663571,SALIX,2012,public,DS-126873,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979472,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_41,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800095,AMPLICON,302,146509562,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",83158451,SALIX,2012,public,DS-126870,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979471,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_42,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V6
SRR5800096,AMPLICON,302,358527454,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",198636255,SALIX,2012,public,DS-125659,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979470,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_49,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V4
SRR5800097,AMPLICON,302,18577228,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",10791933,SALIX,2012,public,DS-126869,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979469,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run1_replicate3_50,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run1_replicate3,SRP110990,V7
SRR5800098,AMPLICON,284,1996590148,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1297616579,SALIX,2012,public,US-1485477,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979776,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_89,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800099,AMPLICON,284,7701512,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",5149372,SALIX,2012,public,US-1484049,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979775,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_110,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800100,AMPLICON,284,1929231312,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1238384425,SALIX,2012,public,US-1484048,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979774,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_109,PAIRED,PCR,METAGENOMIC,human gut metagenome,0532-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800101,AMPLICON,284,1161943684,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",746765351,SALIX,2012,public,US-1485494,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979773,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_106,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800102,AMPLICON,284,1608567196,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1041128696,SALIX,2012,public,US-1484042,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979772,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_105,PAIRED,PCR,METAGENOMIC,human gut metagenome,1673-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800103,AMPLICON,284,4204531676,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",2704186397,SALIX,2012,public,US-1485495,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979771,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_108,PAIRED,PCR,METAGENOMIC,human gut metagenome,1578-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800104,AMPLICON,284,1538892908,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",979566007,SALIX,2012,public,US-1484043,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979770,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_107,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0013,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800105,AMPLICON,284,793200924,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",521971193,SALIX,2012,public,US-1484044,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979769,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_102,PAIRED,PCR,METAGENOMIC,human gut metagenome,0717-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800106,AMPLICON,284,1205178992,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",774157068,SALIX,2012,public,US-1484061,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979768,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_101,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800107,AMPLICON,284,1631099188,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1044324237,SALIX,2012,public,US-1485497,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979767,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_104,PAIRED,PCR,METAGENOMIC,human gut metagenome,1578-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,NA
SRR5800108,AMPLICON,284,926890516,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",590735298,SALIX,2012,public,US-1484045,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979766,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_103,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800109,AMPLICON,284,76957184,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",50057347,SALIX,2012,public,US-1481958,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979765,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_186,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800110,AMPLICON,284,1343343572,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",844191805,SALIX,2012,public,US-1482008,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979764,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_185,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800111,AMPLICON,284,1264872100,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",820220918,SALIX,2012,public,US-1485423,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979763,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_188,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800112,AMPLICON,284,2020982056,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1317892815,SALIX,2012,public,US-1485420,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979762,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_187,PAIRED,PCR,METAGENOMIC,human gut metagenome,1387-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800113,AMPLICON,284,1284260212,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",834652309,SALIX,2012,public,US-1481951,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979761,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_182,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800114,AMPLICON,284,147484892,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",95723635,SALIX,2012,public,US-1482007,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979760,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_181,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800115,AMPLICON,284,946828736,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",606225713,SALIX,2012,public,US-1481953,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979759,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_184,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800116,AMPLICON,284,649493800,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",422203944,SALIX,2012,public,US-1485514,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979758,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_183,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800117,AMPLICON,284,2448601140,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1579670469,SALIX,2012,public,US-1484035,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979757,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_75,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800118,AMPLICON,284,22158816,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",14658563,SALIX,2012,public,US-1485487,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979756,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_76,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800119,AMPLICON,284,2981882708,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1935397436,SALIX,2012,public,US-1484036,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979755,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_77,PAIRED,PCR,METAGENOMIC,human gut metagenome,1417-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800120,AMPLICON,284,1500852244,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",961572194,SALIX,2012,public,US-1485488,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979754,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_78,PAIRED,PCR,METAGENOMIC,human gut metagenome,0961-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800121,AMPLICON,284,1197561544,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",783632949,SALIX,2012,public,US-1485422,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979753,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_190,PAIRED,PCR,METAGENOMIC,human gut metagenome,1387-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800122,AMPLICON,284,1710694448,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1122120072,SALIX,2012,public,US-1485421,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979752,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_189,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800123,AMPLICON,284,1385988160,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",897077941,SALIX,2012,public,US-1484037,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979751,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_73,PAIRED,PCR,METAGENOMIC,human gut metagenome,1673-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800124,AMPLICON,284,1285447900,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",826552027,SALIX,2012,public,US-1484038,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979750,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_74,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800125,AMPLICON,284,1753966960,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1129675643,SALIX,2012,public,US-1485492,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979749,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_81,PAIRED,PCR,METAGENOMIC,human gut metagenome,1415-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800126,AMPLICON,284,1935859304,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1264346715,SALIX,2012,public,US-1485516,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979748,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_179,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800127,AMPLICON,284,2043672236,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1324647068,SALIX,2012,public,US-1481952,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979747,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_180,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800128,AMPLICON,284,1240842008,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",791054424,SALIX,2012,public,US-1481968,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979746,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_171,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800129,AMPLICON,284,1559553056,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1002739176,SALIX,2012,public,US-1482001,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979745,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_172,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800130,AMPLICON,284,4546834888,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",2916254513,SALIX,2012,public,US-1482000,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979744,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_173,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800131,AMPLICON,284,1036669580,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",683112433,SALIX,2012,public,US-1485512,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979743,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_174,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800132,AMPLICON,284,735454920,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",472788641,SALIX,2012,public,US-1482003,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979742,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_175,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800133,AMPLICON,284,15103688,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",10063312,SALIX,2012,public,US-1485510,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979741,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_176,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800134,AMPLICON,284,1462758756,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",972489591,SALIX,2012,public,US-1482005,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979740,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_177,PAIRED,PCR,METAGENOMIC,human gut metagenome,1387-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800135,AMPLICON,284,1609717112,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1023480983,SALIX,2012,public,US-1482004,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979739,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_178,PAIRED,PCR,METAGENOMIC,human gut metagenome,1528-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800136,AMPLICON,284,908613696,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",589077484,SALIX,2012,public,US-1485452,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979738,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_50,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800137,AMPLICON,284,1369783120,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",882414609,SALIX,2012,public,US-1484121,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979737,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_49,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800138,AMPLICON,284,894478164,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",568564199,SALIX,2012,public,US-1485463,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979736,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_42,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800139,AMPLICON,284,47964476,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",31486413,SALIX,2012,public,US-1484109,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979735,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_41,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800140,AMPLICON,284,2343074124,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1549358726,SALIX,2012,public,US-1485462,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979734,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_44,PAIRED,PCR,METAGENOMIC,human gut metagenome,1387-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800141,AMPLICON,284,1427195424,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",934930475,SALIX,2012,public,US-1485464,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979733,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_43,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800142,AMPLICON,284,132466404,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",85785783,SALIX,2012,public,US-1485465,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979732,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_46,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800143,AMPLICON,284,1280727820,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",831740856,SALIX,2012,public,US-1485468,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979731,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_45,PAIRED,PCR,METAGENOMIC,human gut metagenome,1043-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800144,AMPLICON,284,1739363680,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1125042660,SALIX,2012,public,US-1485469,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979730,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_48,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800145,AMPLICON,284,2047110624,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1333122159,SALIX,2012,public,US-1485466,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979729,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_47,PAIRED,PCR,METAGENOMIC,human gut metagenome,1084-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800146,AMPLICON,284,1634766764,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1045956105,SALIX,2012,public,US-1481964,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979728,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_168,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800147,AMPLICON,284,1724820892,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1124413564,SALIX,2012,public,US-1481965,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979727,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_167,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800148,AMPLICON,284,1593330028,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",996147207,SALIX,2012,public,US-1482017,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979726,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_166,PAIRED,PCR,METAGENOMIC,human gut metagenome,0961-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800149,AMPLICON,284,1675135092,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1075157728,SALIX,2012,public,US-1481960,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979725,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_165,PAIRED,PCR,METAGENOMIC,human gut metagenome,1526-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800150,AMPLICON,284,1410018252,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",892655656,SALIX,2012,public,US-1482016,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979724,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_164,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,NA
SRR5800151,AMPLICON,284,1922370440,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1241279502,SALIX,2012,public,US-1482013,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979723,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_163,PAIRED,PCR,METAGENOMIC,human gut metagenome,1526-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800152,AMPLICON,284,1322430948,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",844049822,SALIX,2012,public,US-1482010,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979722,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_162,PAIRED,PCR,METAGENOMIC,human gut metagenome,0961-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800153,AMPLICON,284,1158357900,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",733934535,SALIX,2012,public,US-1484094,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979721,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_161,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800154,AMPLICON,284,810745592,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",518691053,SALIX,2012,public,US-1481969,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979720,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_170,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800155,AMPLICON,284,2257780404,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1500714774,SALIX,2012,public,US-1481967,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979719,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_169,PAIRED,PCR,METAGENOMIC,human gut metagenome,1155-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800156,AMPLICON,284,1696309564,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1107663014,SALIX,2012,public,US-1484123,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979718,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_59,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800157,AMPLICON,284,880883368,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",568291202,SALIX,2012,public,US-1485454,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979717,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_60,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800158,AMPLICON,284,14991224,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",9705511,SALIX,2012,public,US-1485450,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979716,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_53,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800159,AMPLICON,284,831814416,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",533985264,SALIX,2012,public,US-1484120,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979715,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_54,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800160,AMPLICON,284,794062580,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",520657260,SALIX,2012,public,US-1484122,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979714,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_51,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800161,AMPLICON,284,490087724,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",317123902,SALIX,2012,public,US-1485453,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979713,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_52,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800162,AMPLICON,284,5375014104,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",3447520655,SALIX,2012,public,US-1484126,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979712,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_57,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0013,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800163,AMPLICON,284,1519041308,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",999903001,SALIX,2012,public,US-1485457,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979711,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_58,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800164,AMPLICON,284,2269394016,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1500089509,SALIX,2012,public,US-1484125,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979710,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_55,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800165,AMPLICON,284,1955693296,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1252744741,SALIX,2012,public,US-1485456,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979709,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_56,PAIRED,PCR,METAGENOMIC,human gut metagenome,1052-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800166,AMPLICON,284,2050865104,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1324187953,SALIX,2012,public,US-1484086,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979708,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_153,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0019,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800167,AMPLICON,284,918638612,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",581336223,SALIX,2012,public,US-1484087,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979707,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_154,PAIRED,PCR,METAGENOMIC,human gut metagenome,0442-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800168,AMPLICON,284,2643773608,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1711873277,SALIX,2012,public,US-1484088,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979706,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_151,PAIRED,PCR,METAGENOMIC,human gut metagenome,0442-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800169,AMPLICON,284,350069192,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",225679273,SALIX,2012,public,US-1484089,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979705,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_152,PAIRED,PCR,METAGENOMIC,human gut metagenome,0532-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800170,AMPLICON,284,1867834488,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1212653570,SALIX,2012,public,US-1484090,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979704,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_157,PAIRED,PCR,METAGENOMIC,human gut metagenome,0442-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800171,AMPLICON,284,2094652508,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1351292193,SALIX,2012,public,US-1484095,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979703,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_158,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800172,AMPLICON,284,1430068368,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",925393530,SALIX,2012,public,US-1484091,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979702,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_155,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800173,AMPLICON,284,1330637696,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",855247887,SALIX,2012,public,US-1484092,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979701,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_156,PAIRED,PCR,METAGENOMIC,human gut metagenome,1415-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800174,AMPLICON,284,1155392088,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",739839336,SALIX,2012,public,US-1484096,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979700,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_159,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800175,AMPLICON,284,1810741116,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1178827974,SALIX,2012,public,US-1484093,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979699,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_160,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800176,AMPLICON,284,38939808,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",25948616,SALIX,2012,public,US-1484063,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979698,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_99,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800177,AMPLICON,284,1176813640,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",762115573,SALIX,2012,public,US-1484039,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979697,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_79,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800178,AMPLICON,284,1161347852,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",739421875,SALIX,2012,public,US-1484040,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979696,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_80,PAIRED,PCR,METAGENOMIC,human gut metagenome,1417-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800179,AMPLICON,284,1189083576,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",759425603,SALIX,2012,public,US-1485433,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979695,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_30,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800180,AMPLICON,284,600846872,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",385326904,SALIX,2012,public,US-1484102,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979694,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_29,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800181,AMPLICON,284,1358991972,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",878794221,SALIX,2012,public,US-1481991,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979693,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_28,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800182,AMPLICON,284,1797146604,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1157266180,SALIX,2012,public,US-1485432,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979692,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_27,PAIRED,PCR,METAGENOMIC,human gut metagenome,1155-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800183,AMPLICON,284,1557773228,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1023269329,SALIX,2012,public,US-1484101,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979691,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_26,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800184,AMPLICON,284,1283574636,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",829353882,SALIX,2012,public,US-1481992,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979690,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_25,PAIRED,PCR,METAGENOMIC,human gut metagenome,1084-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800185,AMPLICON,284,854289324,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",551330283,SALIX,2012,public,US-1485435,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979689,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_24,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800186,AMPLICON,284,1139431288,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",724908140,SALIX,2012,public,US-1484104,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979688,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_23,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800187,AMPLICON,284,110379156,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",70303365,SALIX,2012,public,US-1485434,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979687,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_22,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800188,AMPLICON,284,1796123920,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1177244088,SALIX,2012,public,US-1484103,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979686,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_21,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800189,AMPLICON,284,1674316036,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1094227538,SALIX,2012,public,US-1485500,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979685,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_142,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,Unscheduled
SRR5800190,AMPLICON,284,5219900404,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",3414484228,SALIX,2012,public,US-1484098,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979684,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_141,PAIRED,PCR,METAGENOMIC,human gut metagenome,0717-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800191,AMPLICON,284,2715781240,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1793740774,SALIX,2012,public,US-1485504,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979683,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_144,PAIRED,PCR,METAGENOMIC,human gut metagenome,1387-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800192,AMPLICON,284,1091074892,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",703979514,SALIX,2012,public,US-1485501,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979682,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_143,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800193,AMPLICON,284,1432023424,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",937980935,SALIX,2012,public,US-1485509,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979681,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_146,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800194,AMPLICON,284,566062836,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",366726062,SALIX,2012,public,US-1485505,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979680,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_145,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800195,AMPLICON,284,979948248,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",633189840,SALIX,2012,public,US-1485507,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979679,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_148,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800196,AMPLICON,284,1277941780,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",831041767,SALIX,2012,public,US-1485506,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979678,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_147,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800197,AMPLICON,284,1152457800,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",749090680,SALIX,2012,public,US-1481949,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979677,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_150,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800198,AMPLICON,284,2636208132,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1696115793,SALIX,2012,public,US-1481946,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979676,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_149,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800199,AMPLICON,284,1474583380,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",948987008,SALIX,2012,public,US-1484031,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979675,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_71,PAIRED,PCR,METAGENOMIC,human gut metagenome,0532-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800200,AMPLICON,284,1726381188,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1112925458,SALIX,2012,public,US-1484032,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979674,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_72,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,NA
SRR5800201,AMPLICON,284,1282603072,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",844589787,SALIX,2012,public,US-1484060,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979673,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_100,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800202,AMPLICON,284,1372429716,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",894635481,SALIX,2012,public,US-1481979,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979672,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_212,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800203,AMPLICON,284,771452488,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",492874564,SALIX,2012,public,US-1485437,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979671,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_39,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800204,AMPLICON,284,2306555700,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1464982523,SALIX,2012,public,US-1481998,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979670,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_40,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800205,AMPLICON,284,1248364600,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",813268755,SALIX,2012,public,US-1484107,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979669,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_31,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800206,AMPLICON,284,875759440,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",558975617,SALIX,2012,public,US-1485438,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979668,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_32,PAIRED,PCR,METAGENOMIC,human gut metagenome,0060-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800207,AMPLICON,284,1707294400,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1090813133,SALIX,2012,public,US-1481993,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979667,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_33,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800208,AMPLICON,284,4680954740,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",3058843410,SALIX,2012,public,US-1484108,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979666,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_34,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800209,AMPLICON,284,1729637248,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1115454036,SALIX,2012,public,US-1485439,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979665,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_35,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800210,AMPLICON,284,2914870920,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1899388628,SALIX,2012,public,US-1484105,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979664,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_36,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800211,AMPLICON,284,1559210836,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",992348083,SALIX,2012,public,US-1485436,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979663,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_37,PAIRED,PCR,METAGENOMIC,human gut metagenome,1578-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800212,AMPLICON,284,857753272,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",543634467,SALIX,2012,public,US-1484106,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979662,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_38,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800213,AMPLICON,284,1259867168,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",802306796,SALIX,2012,public,US-1484041,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979661,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_82,PAIRED,PCR,METAGENOMIC,human gut metagenome,1417-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800214,AMPLICON,284,1352980828,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",886917181,SALIX,2012,public,US-1484073,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979660,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_135,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,Unscheduled
SRR5800215,AMPLICON,284,81604844,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",52785443,SALIX,2012,public,US-1484074,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979659,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_136,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0019,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800216,AMPLICON,284,2146491312,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1403758673,SALIX,2012,public,US-1484071,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979658,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_137,PAIRED,PCR,METAGENOMIC,human gut metagenome,0532-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800217,AMPLICON,284,2874758760,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1833307989,SALIX,2012,public,US-1484072,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979657,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_138,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800218,AMPLICON,284,1035155576,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",666496814,SALIX,2012,public,US-1484065,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979656,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_131,PAIRED,PCR,METAGENOMIC,human gut metagenome,1673-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800219,AMPLICON,284,2439973220,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1613940937,SALIX,2012,public,US-1484068,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979655,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_132,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800220,AMPLICON,284,3575269468,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",2299196273,SALIX,2012,public,US-1484069,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979654,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_133,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800221,AMPLICON,284,1144107064,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",753990741,SALIX,2012,public,US-1484070,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979653,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_134,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800222,AMPLICON,284,1542131644,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1020612309,SALIX,2012,public,US-1485475,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979652,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_86,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800223,AMPLICON,284,2482625476,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1602040449,SALIX,2012,public,US-1485491,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979651,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_85,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800224,AMPLICON,284,1376379020,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",898789595,SALIX,2012,public,US-1485478,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979650,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_88,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800225,AMPLICON,284,563230788,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",370348663,SALIX,2012,public,US-1485472,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979649,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_87,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800226,AMPLICON,284,1764691936,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1155945434,SALIX,2012,public,US-1484099,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979648,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_139,PAIRED,PCR,METAGENOMIC,human gut metagenome,0555-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800227,AMPLICON,284,1678075344,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1062007289,SALIX,2012,public,US-1484097,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979647,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_140,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800228,AMPLICON,284,1315678564,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",861648626,SALIX,2012,public,US-1485490,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979646,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_84,PAIRED,PCR,METAGENOMIC,human gut metagenome,1084-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800229,AMPLICON,284,806315476,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",522446018,SALIX,2012,public,US-1485493,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979645,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_83,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800230,AMPLICON,284,1549929432,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1007441944,SALIX,2012,public,US-1485419,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979644,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_211,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800231,AMPLICON,284,204940932,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",130258528,SALIX,2012,public,US-1484057,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979643,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_96,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800232,AMPLICON,284,1532015280,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",997937086,SALIX,2012,public,US-1484059,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979642,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_95,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800233,AMPLICON,284,3971365972,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",2567186766,SALIX,2012,public,US-1484112,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979641,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_9,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,NA
SRR5800234,AMPLICON,284,1402758076,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",892203792,SALIX,2012,public,US-1485443,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979640,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_10,PAIRED,PCR,METAGENOMIC,human gut metagenome,1155-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800235,AMPLICON,284,1506556384,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",969708287,SALIX,2012,public,US-1484115,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979639,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_7,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800236,AMPLICON,284,1412422880,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",914607025,SALIX,2012,public,US-1485446,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979638,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_8,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800237,AMPLICON,284,465586476,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",289543709,SALIX,2012,public,US-1484114,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979637,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_5,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800238,AMPLICON,284,1300925048,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",835059314,SALIX,2012,public,US-1485445,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979636,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_6,PAIRED,PCR,METAGENOMIC,human gut metagenome,1578-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800239,AMPLICON,284,1410737624,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",896733828,SALIX,2012,public,US-1484111,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979635,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_3,PAIRED,PCR,METAGENOMIC,human gut metagenome,1673-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800240,AMPLICON,284,1622871140,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1046372141,SALIX,2012,public,US-1485442,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979634,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_4,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800241,AMPLICON,284,1268873376,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",834765460,SALIX,2012,public,US-1484110,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979633,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_1,PAIRED,PCR,METAGENOMIC,human gut metagenome,0670-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,NA
SRR5800242,AMPLICON,284,1061444888,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",692737114,SALIX,2012,public,US-1485441,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979632,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_2,PAIRED,PCR,METAGENOMIC,human gut metagenome,0199-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800243,AMPLICON,284,2819598860,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1851832975,SALIX,2012,public,US-1484084,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979631,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_124,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800244,AMPLICON,284,1185436732,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",756843054,SALIX,2012,public,US-1484081,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979630,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_123,PAIRED,PCR,METAGENOMIC,human gut metagenome,1415-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800245,AMPLICON,284,1531875836,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",992152141,SALIX,2012,public,US-1484080,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979629,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_122,PAIRED,PCR,METAGENOMIC,human gut metagenome,1526-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800246,AMPLICON,284,2381643880,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1530721394,SALIX,2012,public,US-1484079,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979628,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_121,PAIRED,PCR,METAGENOMIC,human gut metagenome,1673-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800247,AMPLICON,284,4068798704,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",2644695231,SALIX,2012,public,US-1484066,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979627,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_128,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800248,AMPLICON,284,274383192,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",177018303,SALIX,2012,public,US-1484083,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979626,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_127,PAIRED,PCR,METAGENOMIC,human gut metagenome,0442-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800249,AMPLICON,284,1140268520,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",740919256,SALIX,2012,public,US-1484082,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979625,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_126,PAIRED,PCR,METAGENOMIC,human gut metagenome,1415-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800250,AMPLICON,284,840738832,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",542168451,SALIX,2012,public,US-1484085,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979624,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_125,PAIRED,PCR,METAGENOMIC,human gut metagenome,0442-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800251,AMPLICON,284,1446483000,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",946711944,SALIX,2012,public,US-1484058,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979623,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_97,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800252,AMPLICON,284,1612062384,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1048837701,SALIX,2012,public,US-1484062,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979622,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_98,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800253,AMPLICON,284,999823988,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",641345474,SALIX,2012,public,US-1484064,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979621,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_130,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0039,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800254,AMPLICON,284,963564572,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",621494783,SALIX,2012,public,US-1484067,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979620,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_129,PAIRED,PCR,METAGENOMIC,human gut metagenome,0717-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800255,AMPLICON,284,2237787372,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1437277397,SALIX,2012,public,US-1484053,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979619,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_93,PAIRED,PCR,METAGENOMIC,human gut metagenome,1526-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800256,AMPLICON,284,900729572,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",585045493,SALIX,2012,public,US-1484054,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979618,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_94,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800257,AMPLICON,284,1989465440,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1297310848,SALIX,2012,public,US-1484055,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979617,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_91,PAIRED,PCR,METAGENOMIC,human gut metagenome,1417-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800258,AMPLICON,284,1791397308,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1160207769,SALIX,2012,public,US-1484056,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979616,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_92,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800259,AMPLICON,284,1651912696,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1060467766,SALIX,2012,public,US-1481973,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979615,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_207,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800260,AMPLICON,284,1527363644,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",992216807,SALIX,2012,public,US-1482028,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979614,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_208,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800261,AMPLICON,284,1212386912,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",775761148,SALIX,2012,public,US-1481974,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979613,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_205,PAIRED,PCR,METAGENOMIC,human gut metagenome,1052-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800262,AMPLICON,284,1284997476,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",840644997,SALIX,2012,public,US-1482029,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979612,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_206,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800263,AMPLICON,284,1088351048,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",694187649,SALIX,2012,public,US-1481972,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979611,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_203,PAIRED,PCR,METAGENOMIC,human gut metagenome,1052-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800264,AMPLICON,284,1741002076,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1102597861,SALIX,2012,public,US-1481971,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979610,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_204,PAIRED,PCR,METAGENOMIC,human gut metagenome,1052-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800265,AMPLICON,284,353685080,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",230149439,SALIX,2012,public,US-1481970,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979609,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_201,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800266,AMPLICON,284,1488690512,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",949333595,SALIX,2012,public,US-1482024,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979608,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_202,PAIRED,PCR,METAGENOMIC,human gut metagenome,1528-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800267,AMPLICON,284,1454614772,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",944742558,SALIX,2012,public,US-1481978,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979607,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_209,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800268,AMPLICON,284,1569326632,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",986846936,SALIX,2012,public,US-1485418,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979606,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_210,PAIRED,PCR,METAGENOMIC,human gut metagenome,1578-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800269,AMPLICON,284,1177994796,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",766383085,SALIX,2012,public,US-1485448,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979605,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_17,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800270,AMPLICON,284,1649846312,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1053835498,SALIX,2012,public,US-1482040,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979604,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_18,PAIRED,PCR,METAGENOMIC,human gut metagenome,1155-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800271,AMPLICON,284,816642852,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",530524409,SALIX,2012,public,US-1485447,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979603,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_15,PAIRED,PCR,METAGENOMIC,human gut metagenome,0961-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800272,AMPLICON,284,1290943016,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",835203041,SALIX,2012,public,US-1484117,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979602,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_16,PAIRED,PCR,METAGENOMIC,human gut metagenome,1526-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800273,AMPLICON,284,1389479940,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",898291711,SALIX,2012,public,US-1484119,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979601,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_13,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0019,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800274,AMPLICON,284,1417575208,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",909368889,SALIX,2012,public,US-1484116,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979600,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_14,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0019,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800275,AMPLICON,284,1386111416,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",890866689,SALIX,2012,public,US-1484113,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979599,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_11,PAIRED,PCR,METAGENOMIC,human gut metagenome,0717-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800276,AMPLICON,284,2634585640,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1705725989,SALIX,2012,public,US-1484118,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979598,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_12,PAIRED,PCR,METAGENOMIC,human gut metagenome,0419-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800277,AMPLICON,284,2480169728,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1614002668,SALIX,2012,public,US-1484100,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979597,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_19,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0032,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800278,AMPLICON,284,2398113324,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1556202807,SALIX,2012,public,US-1485431,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979596,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_20,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800279,AMPLICON,284,2170598084,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1392852767,SALIX,2012,public,US-1484075,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979595,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_119,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800280,AMPLICON,284,780729064,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",490928067,SALIX,2012,public,US-1484076,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979594,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_120,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800281,AMPLICON,284,1980297636,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1266578361,SALIX,2012,public,US-1484077,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979593,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_117,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800282,AMPLICON,284,1531633300,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",993783714,SALIX,2012,public,US-1484078,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979592,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_118,PAIRED,PCR,METAGENOMIC,human gut metagenome,1417-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800283,AMPLICON,284,1283011464,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",814226595,SALIX,2012,public,US-1484052,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979591,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_115,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0013,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800284,AMPLICON,284,1302947696,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",840739508,SALIX,2012,public,US-1484050,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979590,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_116,PAIRED,PCR,METAGENOMIC,human gut metagenome,0693-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800285,AMPLICON,284,1917896872,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1237913697,SALIX,2012,public,US-1485499,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979589,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_113,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800286,AMPLICON,284,1264385040,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",810307078,SALIX,2012,public,US-1484051,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979588,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_114,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0013,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800287,AMPLICON,284,1931716596,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1270451251,SALIX,2012,public,US-1484046,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979587,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_111,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800288,AMPLICON,284,815077728,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",517338485,SALIX,2012,public,US-1484047,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979586,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_112,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0013,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800289,AMPLICON,284,1319061572,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",843713316,SALIX,2012,public,US-1485429,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979585,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_197,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800290,AMPLICON,284,868565720,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",563957380,SALIX,2012,public,US-1481988,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979584,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_198,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800291,AMPLICON,284,1684011796,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1093354584,SALIX,2012,public,US-1481986,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979583,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_195,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800292,AMPLICON,284,3164200200,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",2036326938,SALIX,2012,public,US-1481989,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979582,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_196,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800293,AMPLICON,284,1611465416,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1033529090,SALIX,2012,public,US-1481984,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979581,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_193,PAIRED,PCR,METAGENOMIC,human gut metagenome,1052-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800294,AMPLICON,284,1582785960,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1000468805,SALIX,2012,public,US-1481987,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979580,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_194,PAIRED,PCR,METAGENOMIC,human gut metagenome,1528-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,NA
SRR5800295,AMPLICON,284,1722551732,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1111951572,SALIX,2012,public,US-1481983,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979579,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_191,PAIRED,PCR,METAGENOMIC,human gut metagenome,1084-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800296,AMPLICON,284,2188149284,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1414831103,SALIX,2012,public,US-1481982,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979578,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_192,PAIRED,PCR,METAGENOMIC,human gut metagenome,1528-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800297,AMPLICON,284,2464076300,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1619551577,SALIX,2012,public,US-1482020,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979577,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_199,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800298,AMPLICON,284,298731932,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",190874386,SALIX,2012,public,US-1482022,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979576,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_200,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800299,AMPLICON,284,1688295652,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1092874824,SALIX,2012,public,US-1484128,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979575,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_64,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800300,AMPLICON,284,1842279600,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1184299881,SALIX,2012,public,US-1484127,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979574,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_63,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800301,AMPLICON,284,5680000,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",3837354,SALIX,2012,public,US-1485455,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979573,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_62,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800302,AMPLICON,284,1681813068,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1071735893,SALIX,2012,public,US-1484124,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979572,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_61,PAIRED,PCR,METAGENOMIC,human gut metagenome,1415-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800303,AMPLICON,284,2044660272,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1334503935,SALIX,2012,public,US-1485485,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979571,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_68,PAIRED,PCR,METAGENOMIC,human gut metagenome,0961-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V6
SRR5800304,AMPLICON,284,1372470896,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",887238441,SALIX,2012,public,US-1484033,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979570,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_67,PAIRED,PCR,METAGENOMIC,human gut metagenome,0532-0006,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800305,AMPLICON,284,1167332584,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",755119522,SALIX,2012,public,US-1485460,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979569,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_66,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800306,AMPLICON,284,211473784,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",138607298,SALIX,2012,public,US-1485459,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979568,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_65,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V7
SRR5800307,AMPLICON,284,896582036,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",578796856,SALIX,2012,public,US-1485486,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979567,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_70,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V3
SRR5800308,AMPLICON,284,1616726800,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1029536249,SALIX,2012,public,US-1484034,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979566,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_69,PAIRED,PCR,METAGENOMIC,human gut metagenome,1528-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V11
SRR5800309,AMPLICON,284,1660774348,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1105028274,SALIX,2012,public,US-1485480,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979565,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run2_90,PAIRED,PCR,METAGENOMIC,human gut metagenome,1155-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run2,SRP110990,V4
SRR5800311,AMPLICON,284,1316009708,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",763463727,SALIX,2012,public,DS-140830,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979918,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_48,PAIRED,PCR,METAGENOMIC,human gut metagenome,0607-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800312,AMPLICON,284,762288660,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",428103015,SALIX,2012,public,DS-140797,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979917,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_47,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800313,AMPLICON,284,2886369816,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1662205296,SALIX,2012,public,DS-140676,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979916,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_46,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800314,AMPLICON,284,797293932,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",465404824,SALIX,2012,public,DS-140674,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979915,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_45,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800315,AMPLICON,284,1075528164,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",584463121,SALIX,2012,public,DS-140673,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979914,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_44,PAIRED,PCR,METAGENOMIC,human gut metagenome,1633-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800316,AMPLICON,284,945693020,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",509640502,SALIX,2012,public,DS-140793,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979913,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_43,PAIRED,PCR,METAGENOMIC,human gut metagenome,1633-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800317,AMPLICON,284,393401628,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",215919751,SALIX,2012,public,DS-140672,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979912,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_42,PAIRED,PCR,METAGENOMIC,human gut metagenome,1755-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800318,AMPLICON,284,1623091524,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",939764103,SALIX,2012,public,DS-140792,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979911,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_41,PAIRED,PCR,METAGENOMIC,human gut metagenome,1606-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800319,AMPLICON,284,369025056,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",198087350,SALIX,2012,public,DS-140710,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979910,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_50,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0036,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800320,AMPLICON,284,1167739272,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",643851571,SALIX,2012,public,DS-140677,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979909,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_49,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0036,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800321,AMPLICON,284,1174632804,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",642586015,SALIX,2012,public,DS-140661,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979908,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_115,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0036,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800322,AMPLICON,284,2087142980,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1198177616,SALIX,2012,public,DS-140782,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979907,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_116,PAIRED,PCR,METAGENOMIC,human gut metagenome,1590-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800323,AMPLICON,284,1713964424,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",983637032,SALIX,2012,public,DS-140662,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979906,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_117,PAIRED,PCR,METAGENOMIC,human gut metagenome,1165-0024,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800324,AMPLICON,284,2499624012,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1355624975,SALIX,2012,public,DS-140663,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979905,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_118,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0073,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800325,AMPLICON,284,650412540,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",373937286,SALIX,2012,public,DS-140707,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979904,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_111,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800326,AMPLICON,284,1899021096,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1097364326,SALIX,2012,public,DS-140828,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979903,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_112,PAIRED,PCR,METAGENOMIC,human gut metagenome,1590-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800327,AMPLICON,284,760179108,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",447364076,SALIX,2012,public,DS-140780,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979902,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_113,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0048,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800328,AMPLICON,284,754953508,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",412753827,SALIX,2012,public,DS-140660,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979901,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_114,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0073,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800329,AMPLICON,284,340479080,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",195619514,SALIX,2012,public,DS-140784,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979900,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_119,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800330,AMPLICON,284,1036827768,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",564359357,SALIX,2012,public,DS-140664,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979899,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_120,PAIRED,PCR,METAGENOMIC,human gut metagenome,1633-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800331,AMPLICON,284,1413077784,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",810044210,SALIX,2012,public,DS-140831,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979898,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_51,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800332,AMPLICON,284,462259416,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",270760493,SALIX,2012,public,DS-140740,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979897,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_52,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,Unscheduled
SRR5800333,AMPLICON,284,89942232,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",48522387,SALIX,2012,public,DS-140733,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979896,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_53,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800334,AMPLICON,284,822224304,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",487381080,SALIX,2012,public,DS-140734,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979895,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_54,PAIRED,PCR,METAGENOMIC,human gut metagenome,1429-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800335,AMPLICON,284,1754450896,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1013400113,SALIX,2012,public,DS-140735,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979894,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_55,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800336,AMPLICON,284,1650190804,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",937348395,SALIX,2012,public,DS-140736,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979893,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_56,PAIRED,PCR,METAGENOMIC,human gut metagenome,1320-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800337,AMPLICON,284,570205544,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",335945860,SALIX,2012,public,DS-140737,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979892,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_57,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800338,AMPLICON,284,579840812,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",335077795,SALIX,2012,public,DS-140738,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979891,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_58,PAIRED,PCR,METAGENOMIC,human gut metagenome,0607-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800339,AMPLICON,284,385682508,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",222011246,SALIX,2012,public,DS-140739,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979890,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_59,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0020,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800340,AMPLICON,284,1803433796,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1044354707,SALIX,2012,public,DS-140692,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979889,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_60,PAIRED,PCR,METAGENOMIC,human gut metagenome,1429-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800341,AMPLICON,284,1446304364,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",844465829,SALIX,2012,public,DS-140703,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979888,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_104,PAIRED,PCR,METAGENOMIC,human gut metagenome,1125-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800342,AMPLICON,284,1491969292,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",810527635,SALIX,2012,public,DS-140702,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979887,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_103,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0047,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800343,AMPLICON,284,1273874616,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",691148995,SALIX,2012,public,DS-140669,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979886,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_102,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800344,AMPLICON,284,568328304,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",320736570,SALIX,2012,public,DS-140701,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979885,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_101,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800345,AMPLICON,284,1064066776,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",576096964,SALIX,2012,public,DS-140826,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979884,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_108,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800346,AMPLICON,284,1913449432,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1110865497,SALIX,2012,public,DS-140705,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979883,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_107,PAIRED,PCR,METAGENOMIC,human gut metagenome,1098-0026,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800347,AMPLICON,284,1387984680,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",809292032,SALIX,2012,public,DS-140704,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979882,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_106,PAIRED,PCR,METAGENOMIC,human gut metagenome,0607-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800348,AMPLICON,284,4779525460,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",2780995740,SALIX,2012,public,DS-140824,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979881,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_105,PAIRED,PCR,METAGENOMIC,human gut metagenome,1098-0026,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800349,AMPLICON,284,3277680636,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1884634992,SALIX,2012,public,DS-140827,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979880,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_110,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800350,AMPLICON,284,311806440,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",183169309,SALIX,2012,public,DS-140706,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979879,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_109,PAIRED,PCR,METAGENOMIC,human gut metagenome,1082-0024,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800351,AMPLICON,284,735792880,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",442077363,SALIX,2012,public,DS-140732,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979878,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_70,PAIRED,PCR,METAGENOMIC,human gut metagenome,0498-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800352,AMPLICON,284,845134016,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",478310295,SALIX,2012,public,DS-140699,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979877,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_69,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800353,AMPLICON,284,1450323532,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",852944814,SALIX,2012,public,DS-140730,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979876,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_66,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0020,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800354,AMPLICON,284,2684219752,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1468133307,SALIX,2012,public,DS-140697,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979875,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_65,PAIRED,PCR,METAGENOMIC,human gut metagenome,1755-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800355,AMPLICON,284,965730356,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",568244789,SALIX,2012,public,DS-140731,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979874,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_68,PAIRED,PCR,METAGENOMIC,human gut metagenome,1446-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800356,AMPLICON,284,558092660,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",314706804,SALIX,2012,public,DS-140698,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979873,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_67,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800357,AMPLICON,284,469190436,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",277487604,SALIX,2012,public,DS-140694,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979872,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_62,PAIRED,PCR,METAGENOMIC,human gut metagenome,1098-0026,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800358,AMPLICON,284,1744627336,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1008601698,SALIX,2012,public,DS-140693,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979871,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_61,PAIRED,PCR,METAGENOMIC,human gut metagenome,0716-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800359,AMPLICON,284,34142764,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",19823479,SALIX,2012,public,DS-140696,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979870,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_64,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0069,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800360,AMPLICON,284,721917776,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",420944772,SALIX,2012,public,DS-140695,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979869,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_63,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800361,AMPLICON,284,939084624,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",513503067,SALIX,2012,public,DS-140653,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979868,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_139,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800362,AMPLICON,284,1374047948,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",744142657,SALIX,2012,public,DS-140654,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979867,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_140,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800363,AMPLICON,284,466821024,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",262672368,SALIX,2012,public,DS-140651,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979866,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_137,PAIRED,PCR,METAGENOMIC,human gut metagenome,1320-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800364,AMPLICON,284,1147091904,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",678815565,SALIX,2012,public,DS-140652,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979865,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_138,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800365,AMPLICON,284,1912263732,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1125513136,SALIX,2012,public,DS-140770,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979864,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_135,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0048,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800366,AMPLICON,284,472655236,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",275966435,SALIX,2012,public,DS-140771,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979863,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_136,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800367,AMPLICON,284,1419297384,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",816191084,SALIX,2012,public,DS-140813,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979862,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_133,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800368,AMPLICON,284,1305080252,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",765170930,SALIX,2012,public,DS-140816,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979861,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_134,PAIRED,PCR,METAGENOMIC,human gut metagenome,1590-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800369,AMPLICON,284,1127991200,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",617277015,SALIX,2012,public,DS-140812,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979860,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_131,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800370,AMPLICON,284,666309724,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",388294562,SALIX,2012,public,DS-140659,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979859,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_132,PAIRED,PCR,METAGENOMIC,human gut metagenome,1551-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800371,AMPLICON,284,898291148,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",520590329,SALIX,2012,public,DS-140649,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979858,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_79,PAIRED,PCR,METAGENOMIC,human gut metagenome,1446-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800372,AMPLICON,284,2039480112,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1171489522,SALIX,2012,public,DS-140803,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979857,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_80,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800373,AMPLICON,284,733071024,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",423562218,SALIX,2012,public,DS-140647,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979856,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_77,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800374,AMPLICON,284,175810484,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",97836101,SALIX,2012,public,DS-140648,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979855,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_78,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800375,AMPLICON,284,559800068,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",307648589,SALIX,2012,public,DS-140646,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979854,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_75,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800376,AMPLICON,284,913786188,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",494490255,SALIX,2012,public,DS-140800,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979853,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_76,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0059,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800377,AMPLICON,284,2026144892,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1144639359,SALIX,2012,public,DS-140645,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979852,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_73,PAIRED,PCR,METAGENOMIC,human gut metagenome,1165-0024,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800378,AMPLICON,284,922787000,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",538797388,SALIX,2012,public,DS-140766,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979851,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_74,PAIRED,PCR,METAGENOMIC,human gut metagenome,0607-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800379,AMPLICON,284,2707918700,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1486533807,SALIX,2012,public,DS-140807,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979850,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_71,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800380,AMPLICON,284,1618826696,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",940309808,SALIX,2012,public,DS-140809,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979849,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_72,PAIRED,PCR,METAGENOMIC,human gut metagenome,1590-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800381,AMPLICON,284,2185908240,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1252104215,SALIX,2012,public,DS-140779,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979848,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_130,PAIRED,PCR,METAGENOMIC,human gut metagenome,1606-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800382,AMPLICON,284,1581477572,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",883589088,SALIX,2012,public,DS-140778,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979847,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_129,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800383,AMPLICON,284,819774236,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",450058918,SALIX,2012,public,DS-140819,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979846,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_126,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800384,AMPLICON,284,507609956,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",290570967,SALIX,2012,public,DS-140818,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979845,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_125,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800385,AMPLICON,284,1244237512,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",674046042,SALIX,2012,public,DS-140657,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979844,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_128,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0059,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800386,AMPLICON,284,565931344,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",338441314,SALIX,2012,public,DS-140656,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979843,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_127,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800387,AMPLICON,284,3573455276,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",2075454934,SALIX,2012,public,DS-140786,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979842,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_122,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800388,AMPLICON,284,424811176,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",251459813,SALIX,2012,public,DS-140665,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979841,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_121,PAIRED,PCR,METAGENOMIC,human gut metagenome,1429-0002,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800389,AMPLICON,284,1264140800,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",724043216,SALIX,2012,public,DS-140787,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979840,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_124,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0007,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800390,AMPLICON,284,1042174068,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",576122730,SALIX,2012,public,DS-140666,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979839,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_123,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800391,AMPLICON,284,2524026144,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1481496437,SALIX,2012,public,DS-140642,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979838,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_84,PAIRED,PCR,METAGENOMIC,human gut metagenome,1125-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800392,AMPLICON,284,1343976324,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",722506476,SALIX,2012,public,DS-140641,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979837,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_83,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0059,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800393,AMPLICON,284,1150264184,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",678463778,SALIX,2012,public,DS-140761,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979836,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_82,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0069,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800394,AMPLICON,284,1378402236,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",799203886,SALIX,2012,public,DS-140760,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979835,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_81,PAIRED,PCR,METAGENOMIC,human gut metagenome,0716-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800395,AMPLICON,284,1774592460,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1024793477,SALIX,2012,public,DS-140765,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979834,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_88,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800396,AMPLICON,284,3823792756,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",2207325060,SALIX,2012,public,DS-140644,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979833,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_87,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800397,AMPLICON,284,3030560876,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1757384546,SALIX,2012,public,DS-140643,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979832,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_86,PAIRED,PCR,METAGENOMIC,human gut metagenome,1551-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800398,AMPLICON,284,432176432,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",247132010,SALIX,2012,public,DS-140763,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979831,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_85,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0069,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800399,AMPLICON,284,1244478344,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",731129433,SALIX,2012,public,DS-140757,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979830,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_90,PAIRED,PCR,METAGENOMIC,human gut metagenome,0498-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800400,AMPLICON,284,1214785860,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",706013036,SALIX,2012,public,DS-140755,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979829,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_89,PAIRED,PCR,METAGENOMIC,human gut metagenome,1590-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800401,AMPLICON,284,3175684876,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1747152420,SALIX,2012,public,DS-140685,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979828,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_15,PAIRED,PCR,METAGENOMIC,human gut metagenome,1742-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800402,AMPLICON,284,2893496228,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1698347043,SALIX,2012,public,DS-140686,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979827,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_16,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0048,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800403,AMPLICON,284,1228987848,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",660875131,SALIX,2012,public,DS-140840,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979826,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_17,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800404,AMPLICON,284,105372520,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",57384329,SALIX,2012,public,DS-140687,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979825,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_18,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800405,AMPLICON,284,2192916508,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1280175445,SALIX,2012,public,DS-140681,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979824,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_11,PAIRED,PCR,METAGENOMIC,human gut metagenome,1098-0026,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800406,AMPLICON,284,1402284648,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",813964768,SALIX,2012,public,DS-140682,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979823,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_12,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800407,AMPLICON,284,518083876,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",285626577,SALIX,2012,public,DS-140683,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979822,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_13,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0073,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800408,AMPLICON,284,1093737676,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",593730634,SALIX,2012,public,DS-140684,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979821,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_14,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800409,AMPLICON,284,1862226056,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1016409013,SALIX,2012,public,DS-140720,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979820,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_19,PAIRED,PCR,METAGENOMIC,human gut metagenome,1742-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800410,AMPLICON,284,749782152,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",442846857,SALIX,2012,public,DS-140688,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979819,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_20,PAIRED,PCR,METAGENOMIC,human gut metagenome,1098-0026,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800411,AMPLICON,284,963313516,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",523831344,SALIX,2012,public,DS-140821,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979818,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_99,PAIRED,PCR,METAGENOMIC,human gut metagenome,1633-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800412,AMPLICON,284,1000090380,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",566326135,SALIX,2012,public,DS-140668,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979817,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_100,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800413,AMPLICON,284,2015716980,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1154014604,SALIX,2012,public,DS-140655,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979816,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_141,PAIRED,PCR,METAGENOMIC,human gut metagenome,1320-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800414,AMPLICON,284,1455305460,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",800240777,SALIX,2012,public,DS-140709,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979815,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_95,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V7
SRR5800415,AMPLICON,284,503924204,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",293754024,SALIX,2012,public,DS-140667,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979814,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_96,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800416,AMPLICON,284,2380288348,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1384817112,SALIX,2012,public,DS-140700,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979813,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_97,PAIRED,PCR,METAGENOMIC,human gut metagenome,0867-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800417,AMPLICON,284,1211332988,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",693979602,SALIX,2012,public,DS-140788,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979812,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_98,PAIRED,PCR,METAGENOMIC,human gut metagenome,1595-0014,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800418,AMPLICON,284,942155800,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",552956044,SALIX,2012,public,DS-140751,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979811,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_91,PAIRED,PCR,METAGENOMIC,human gut metagenome,0852-0021,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800419,AMPLICON,284,1247328852,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",680439573,SALIX,2012,public,DS-140790,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979810,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_92,PAIRED,PCR,METAGENOMIC,human gut metagenome,1606-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800420,AMPLICON,284,1579976916,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",867770231,SALIX,2012,public,DS-140708,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979809,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_93,PAIRED,PCR,METAGENOMIC,human gut metagenome,1742-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800421,AMPLICON,284,2913185380,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1662121760,SALIX,2012,public,DS-140829,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979808,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_94,PAIRED,PCR,METAGENOMIC,human gut metagenome,1131-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800422,AMPLICON,284,1716720360,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",993340375,SALIX,2012,public,DS-140680,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979807,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_22,PAIRED,PCR,METAGENOMIC,human gut metagenome,0498-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800423,AMPLICON,284,1282006104,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",746751706,SALIX,2012,public,DS-140721,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979806,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_21,PAIRED,PCR,METAGENOMIC,human gut metagenome,0607-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800424,AMPLICON,284,323397048,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",188155868,SALIX,2012,public,DS-140678,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979805,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_24,PAIRED,PCR,METAGENOMIC,human gut metagenome,1131-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800425,AMPLICON,284,576646948,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",316540768,SALIX,2012,public,DS-140719,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979804,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_23,PAIRED,PCR,METAGENOMIC,human gut metagenome,1633-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800426,AMPLICON,284,1135096596,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",622613351,SALIX,2012,public,DS-140799,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979803,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_26,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800427,AMPLICON,284,330499320,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",184487736,SALIX,2012,public,DS-140711,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979802,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_25,PAIRED,PCR,METAGENOMIC,human gut metagenome,1692-0011,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800428,AMPLICON,284,934778332,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",542033564,SALIX,2012,public,DS-140679,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979801,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_28,PAIRED,PCR,METAGENOMIC,human gut metagenome,0716-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800429,AMPLICON,284,1024758620,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",588013778,SALIX,2012,public,DS-140832,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979800,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_27,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800430,AMPLICON,284,1558779440,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",921745167,SALIX,2012,public,DS-140833,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979799,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_30,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0048,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800431,AMPLICON,284,922101992,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",501671030,SALIX,2012,public,DS-140712,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979798,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_29,PAIRED,PCR,METAGENOMIC,human gut metagenome,1755-0016,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800432,AMPLICON,284,674525560,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",361998364,SALIX,2012,public,DS-140715,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979797,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_33,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0036,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800433,AMPLICON,284,1654006060,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",957682865,SALIX,2012,public,DS-140836,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979796,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_34,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800434,AMPLICON,284,843800352,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",497744956,SALIX,2012,public,DS-140713,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979795,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_31,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0048,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800435,AMPLICON,284,1445297016,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",780839147,SALIX,2012,public,DS-140714,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979794,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_32,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0010,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800436,AMPLICON,284,1687945196,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",922739084,SALIX,2012,public,DS-140838,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979793,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_37,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0015,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V6
SRR5800437,AMPLICON,284,468742000,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",272654998,SALIX,2012,public,DS-140718,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979792,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_38,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0020,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800438,AMPLICON,284,2863344800,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1663546514,SALIX,2012,public,DS-140716,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979791,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_35,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0017,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800439,AMPLICON,284,12204048,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",7969994,SALIX,2012,public,DS-140717,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979790,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_36,PAIRED,PCR,METAGENOMIC,human gut metagenome,1165-0024,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800440,AMPLICON,284,503767720,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",275167587,SALIX,2012,public,DS-140670,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979789,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_39,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0043,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800441,AMPLICON,284,289988424,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",168989648,SALIX,2012,public,DS-140791,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979788,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_40,PAIRED,PCR,METAGENOMIC,human gut metagenome,1598-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800442,AMPLICON,284,1529862560,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",883622767,SALIX,2012,public,DS-140691,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979787,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_1,PAIRED,PCR,METAGENOMIC,human gut metagenome,1131-0009,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800443,AMPLICON,284,1247972680,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",685836779,SALIX,2012,public,DS-140689,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979786,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_2,PAIRED,PCR,METAGENOMIC,human gut metagenome,1617-0001,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800444,AMPLICON,284,797303304,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",471340005,SALIX,2012,public,DS-140722,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979785,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_3,PAIRED,PCR,METAGENOMIC,human gut metagenome,1125-0004,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800445,AMPLICON,284,1584839848,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",912463999,SALIX,2012,public,DS-140723,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979784,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_4,PAIRED,PCR,METAGENOMIC,human gut metagenome,1551-0003,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800446,AMPLICON,284,336204312,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",197950139,SALIX,2012,public,DS-140724,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979783,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_5,PAIRED,PCR,METAGENOMIC,human gut metagenome,1082-0024,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800447,AMPLICON,284,1693361928,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",912025892,SALIX,2012,public,DS-140725,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979782,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_6,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0047,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800448,AMPLICON,284,824113472,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",445920796,SALIX,2012,public,DS-140726,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979781,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_7,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0047,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V11
SRR5800449,AMPLICON,284,1387370956,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",793787586,SALIX,2012,public,DS-140727,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979780,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_8,PAIRED,PCR,METAGENOMIC,human gut metagenome,1446-0005,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V3
SRR5800450,AMPLICON,284,1018599796,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",556897103,SALIX,2012,public,DS-140728,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979779,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_9,PAIRED,PCR,METAGENOMIC,human gut metagenome,1651-0036,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800451,AMPLICON,284,239805908,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",140577316,SALIX,2012,public,DS-140729,OL Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979778,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,run3_10,PAIRED,PCR,METAGENOMIC,human gut metagenome,1082-0024,ILLUMINA,2018-07-31T00:00:00Z,Rifaximin treated samples,run3,SRP110990,V4
SRR5800452,AMPLICON,284,184542348,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",103104990,SALIX,2012,public,US-1484057,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979952,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_3,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800453,AMPLICON,284,3583368580,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1968821486,SALIX,2012,public,US-1485465,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979951,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_4,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V4
SRR5800454,AMPLICON,284,3561969464,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1992013651,SALIX,2012,public,US-1484076,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979950,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_1,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V7
SRR5800455,AMPLICON,284,3278550244,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1835509970,SALIX,2012,public,US-1484114,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979949,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_2,PAIRED,PCR,METAGENOMIC,human gut metagenome,1432-0004,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800456,AMPLICON,284,2179867844,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1222933791,SALIX,2012,public,US-1485447,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979948,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_7,PAIRED,PCR,METAGENOMIC,human gut metagenome,0961-0014,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800457,AMPLICON,284,3036873344,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1706932358,SALIX,2012,public,US-1481969,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979947,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_8,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800458,AMPLICON,284,72886044,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",43241305,SALIX,2012,public,US-1485487,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979946,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_5,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0008,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800459,AMPLICON,284,261606316,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",146513611,SALIX,2012,public,US-1485505,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979945,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_6,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V4
SRR5800460,AMPLICON,284,26090512,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",16747529,SALIX,2012,public,US-1484063,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979944,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_9,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0038,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800461,AMPLICON,284,2514634832,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",1399253543,SALIX,2012,public,US-1485493,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979943,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_10,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V7
SRR5800462,AMPLICON,284,2604377412,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1466659850,SALIX,2012,public,US-1485459,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979942,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_30,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V7
SRR5800463,AMPLICON,284,1667249548,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",941386177,SALIX,2012,public,US-1485437,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979941,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_29,PAIRED,PCR,METAGENOMIC,human gut metagenome,1636-0003,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V7
SRR5800464,AMPLICON,284,1039578876,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",582191509,SALIX,2012,public,US-1484047,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979940,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_24,PAIRED,PCR,METAGENOMIC,human gut metagenome,1522-0013,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800465,AMPLICON,284,2818611392,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1602766500,SALIX,2012,public,US-1482003,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979939,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_23,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0014,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V4
SRR5800466,AMPLICON,284,3861438660,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",2188044822,SALIX,2012,public,US-1481970,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979938,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_22,PAIRED,PCR,METAGENOMIC,human gut metagenome,1548-0007,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V4
SRR5800467,AMPLICON,284,3269410272,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1815277525,SALIX,2012,public,US-1484049,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979937,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_21,PAIRED,PCR,METAGENOMIC,human gut metagenome,1481-0006,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800468,AMPLICON,284,39654352,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",22700164,SALIX,2012,public,US-1482007,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979936,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_28,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800469,AMPLICON,284,6427772,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",4058253,SALIX,2012,public,US-1485510,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979935,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_27,PAIRED,PCR,METAGENOMIC,human gut metagenome,1545-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800470,AMPLICON,284,8474844,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",5827603,SALIX,2012,public,US-1485455,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979934,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_26,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V4
SRR5800471,AMPLICON,284,428819268,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",236666198,SALIX,2012,public,US-1484102,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979933,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_25,PAIRED,PCR,METAGENOMIC,human gut metagenome,1534-0005,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800472,AMPLICON,284,3235987732,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1805762528,SALIX,2012,public,US-1484109,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979932,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_32,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800473,AMPLICON,284,381289596,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",215301452,SALIX,2012,public,US-1485514,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979931,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_31,PAIRED,PCR,METAGENOMIC,human gut metagenome,0363-0005,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800474,AMPLICON,284,497692676,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",275807961,SALIX,2012,public,US-1484089,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979930,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_13,PAIRED,PCR,METAGENOMIC,human gut metagenome,0532-0006,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800475,AMPLICON,284,2279676236,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1417799897,SALIX,2012,public,US-1484122,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979929,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_14,PAIRED,PCR,METAGENOMIC,human gut metagenome,0672-0002,ILLUMINA,2017-09-18T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800476,AMPLICON,284,2943944,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1786712,SALIX,2012,public,US-1484083,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979928,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_11,PAIRED,PCR,METAGENOMIC,human gut metagenome,0442-0004,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800477,AMPLICON,284,1179012084,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",664935361,SALIX,2012,public,US-1484044,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979927,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_12,PAIRED,PCR,METAGENOMIC,human gut metagenome,0717-0011,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800478,AMPLICON,284,1287462596,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",718756805,SALIX,2012,public,US-1485472,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979926,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_17,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V6
SRR5800479,AMPLICON,284,1397407516,PRJNA391915,SAMN07277992,"MIMS.me,MIGS/MIMS/MIMARKS.human-gut",798916409,SALIX,2012,public,US-1484120,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979925,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_18,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800480,AMPLICON,284,1023580020,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",584087430,SALIX,2012,public,US-1485453,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979924,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_15,PAIRED,PCR,METAGENOMIC,human gut metagenome,1095-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V7
SRR5800481,AMPLICON,284,12408244,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",8358236,SALIX,2012,public,US-1485450,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979923,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_16,PAIRED,PCR,METAGENOMIC,human gut metagenome,1182-0008,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800482,AMPLICON,284,459052204,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",257376078,SALIX,2012,public,US-1481958,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979922,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_33,PAIRED,PCR,METAGENOMIC,human gut metagenome,0831-0005,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800483,AMPLICON,284,2563555252,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",1439126298,SALIX,2012,public,US-1485434,DB Rifaximin 550 mg TID,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979921,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_19,PAIRED,PCR,METAGENOMIC,human gut metagenome,1049-0002,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V11
SRR5800484,AMPLICON,284,129559380,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",72219256,SALIX,2012,public,US-1482022,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979920,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_20,PAIRED,PCR,METAGENOMIC,human gut metagenome,1047-0012,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V3
SRR5800485,AMPLICON,284,7178961372,PRJNA391915,SAMN07277992,"MIGS/MIMS/MIMARKS.human-gut,MIMS.me",4019291051,SALIX,2012,public,US-1484074,DB Placebo,"fastq,sra","gs,ncbi,s3","gs.US,ncbi.public,s3.us-east-1",human gut,fecal samples,fecal samples,SRX2979919,USA,North America,USA,Homo sapiens,Illumina HiSeq 2500,37.0902 N 95.7129 W,rerun_34,PAIRED,PCR,METAGENOMIC,human gut metagenome,0775-0019,ILLUMINA,2017-07-03T00:00:00Z,Rifaximin treated samples,rerun,SRP110990,V7
